Brilliant Violet 421™ anti-human CD14 Antibo
- 产品名称：
- Brilliant Violet 421™ anti-human CD14 Antibo
- 产品类别：
- 抗体
- 产品编号：
- 301829
- 产品应用：
- 301829
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 2448 |
1 |
- Verified Reactivity
- Human, Cynomolgus, Rhesus
- Reported Reactivity
- African Green, Capuchin Monkey, Cow, Chimpanzee, Common Marmoset, Cotton-topped Tamarin, Dog, Pigtailed Macaque, Squirrel Monkey
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Full-length human CD14 protein
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA).
- Preparation
- The antibody was purified by affinity chromatography and conjugated with Brilliant Violet 421? under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
Brilliant Violet 421? excites at 405 nm and emits at 421 nm. The standard bandpass filter 450/50 nm is recommended for detection. Brilliant Violet 421? is a trademark of Sirigen Group Ltd.
Learn more about Brilliant Violet?.
This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. - Excitation Laser
- Violet Laser (405 nm)
- Application Notes
The M5E2 antibody inhibits monocyte activation and cytokine production induced by LPS. Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen sections, blocking of LPS stimulation4, and immunofluorescence microscopy5. Clone M5E2 is not recommended for immunohistochemical staining of formalin-fixed paraffin-embedded sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 301861 and 301862).
- Application References
(PubMed link indicates BioLegend citation) -
- McMichael A, et al. 1987. Leucocyte Typing III. Oxford University Press. New York.
- Knapp W, et al. Eds. 1989. Leucocyte Typing IV. Oxford University Press. New York. (IHC-F)
- Schlossman S, et al. Eds. 1995. Leucocyte Typing V. Oxford University Press. New York.
- Power CP, et al. 2004. J. Immunol. 173:5229. (Block)
- Williams KC, et al. 2001. J. Exp. Med. 193:905.
- Iwamoto S, et al. 2007. J. Immunol. 179:1449. (FC) PubMed
- Santer DM, et al. 2010. J. Immunol. 485:4739. PubMed
- Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
- Zizzo G, et al. 2012. J. Immunol. 189:3508. PubMed
- Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
- Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
- Product Citations
-
- Silvin A, et al. 2020. Cell. 182:1401. PubMed
- Juul-Madsen K, et al. 2020. J Immunol. 1345:204. PubMed
- van der Wijst MGP, et al. 2021. Sci Transl Med. 13:eabh2624. PubMed
- Haynes A, et al. 2018. J Appl Physiol (1985). 125:401. PubMed
- Porbahaie M, et al. 2022. Nutrients. 14:. PubMed
- Wu Q, et al. 2018. Mol Med Rep. 18:564. PubMed
- Evren E, et al. 2020. Immunity. 54(2):259-275.e7. PubMed
- Laing AG, et al. 2020. Nat Med. 26:1623. PubMed
- Lende SSF, et al. 2022. Front Cell Infect Microbiol. 12:919097. PubMed
- Haynes A, et al. 2016. Physiol Rep. 4: e12951. PubMed
- Willingham SB, et al. 2018. Cancer Immunol Res. 6:1136. PubMed
- Cheng C, et al. 2020. Cell Reports. 32(5):107981. PubMed
- Kong R, et al. 2019. Cell. 178:567. PubMed
- Sabree SA, et al. 2021. J Immunother Cancer. 9: . PubMed
- Maheshwari D, et al. 2022. iScience. 25:104384. PubMed
- Norton S, et al. 2016. Clin Transl Immunology. 5: e76. PubMed
- Cui D, et al. 2021. Front Cell Dev Biol. 9:656867. PubMed
- Gadd V, et al. 2016. PLoS One. 11: 0157771. PubMed
- Li C, et al. 2017. Virulence. 8:1833. PubMed
- Buters TP, et al. 2021. Br J Clin Pharmacol. Online ahead of print. PubMed
- Rainho J, et al. 2015. J Virol. 89: 10625 - 10636. PubMed
- Teijeira á, et al. 2020. Immunity. 52(5):856-871. PubMed
- Ronaghan NJ, et al. 2022. PLoS One. 17:e0276013. PubMed
- Siedlik J, et al. 2017. J Immunol Methods. 10.4049/jimmunol.1700003. PubMed
- Vierboom MPM, et al. 2021. Cell Reports Medicine. 2(1):100185. PubMed
- Pinkert J, et al. 2022. Oncoimmunology. 11:2008110. PubMed
- Tomellini E, et al. 2020. Cell Reports. 28(4):1063-1073.e5.. PubMed
- RRID
- AB_10899407 (BioLegend Cat. No. 301829) AB_10959324 (BioLegend Cat. No. 301830)
- Structure
- GPI-linked membrane glycoprotein, 53-55 kD
- Distribution
-
Monocytes, macrophages, granulocytes (low)
- Function
- LPS receptor, clearance of Gram-negative pathogens
- Ligand/Receptor
- LPS
- Cell Type
- Granulocytes, Macrophages, Monocytes, Neutrophils
- Biology Area
- Cell Biology, Immunology, Innate Immunity, Neuroinflammation, Neuroscience
- Molecular Family
- CD Molecules
- Antigen References
-
1. Stocks S, et al. 1990. Biochem. J. 268:275.
2. Wright S, et al. 1990. Science 249:1434.
- Gene ID
- 929 View all products for this Gene ID
- UniProt
- View information about CD14 on UniProt.org
